Belgium Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Global Markets Direct, September 2009, Pages: 68

Belgium Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Belgium drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices market in Belgium

Scope

- The report provides information on the drug delivery devices market in Belgium.
- Details on the key segments and categories such as Inhalation Systems, Needle Free Injections, and Infusion Systems.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors such as AstraZeneca International plc, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Baxter International Inc., and Hospira, Inc.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the drug delivery devices market in Belgium.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
3.1 Drug Delivery Devices
3.2 Inhalation Systems
3.2.1 Metered Dose Inhaler
3.2.2 Dry Powder Inhaler
3.3 Infusion Systems
3.3.1 Infusion Pumps
3.3.2 Syringe Pumps
3.3.3 Disposable Infusion Sets
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.2.1 Healthcare Personnel Data
4.2.2 Healthcare Facilities Data
4.3 Healthcare Policy
5 Regulation System
5.1 Medical Equipment Approval Process
5.1.1 Classification
5.1.2 Conformity Assessment Process
5.1.2.1 Class I devices
5.1.2.2 Class IIa devices
5.1.2.3 Class IIb devices
5.1.2.4 Class III devices
5.2 Notification Fee
6 Pricing and Reimbursement
6.1 Reimbursement Policies
7 Distribution Structure
8 Drug Delivery Devices In Belgium
8.1 Drug Delivery Devices, Belgium, Overall Revenue ($ mn), 2000-2015
8.2 Drug Delivery Devices, Belgium, Category Volume (Units), 2000-2015
8.3 Drug Delivery Devices, Belgium, Company Share (2007-2008)
9 Infusion Systems In Belgium
9.1 Infusion Systems Overall Revenue (2000-2015)
9.2 Infusion Systems Overall Volume (2000-2015)
9.3 Infusion Systems Average Price (2000-2015)
9.4 Infusion Systems Distribution Share (2007-2008)
9.5 Infusion Systems, Belgium, Company Share (2007-2008)
10 Inhalation Systems In Belgium
10.1 Inhalation Systems Overall Revenue (2000-2015)
10.2 Inhalation Systems Overall Volume (2000-2015)
10.3 Inhalation Systems Average Price (2000-2015)
10.4 Inhalation Systems Distribution Share (2007-2008)
10.5 Inhalation Systems, Belgium, Company Share (2007-2008)
11 Overview of Key Companies in Belgium Drug Delivery Devices Market
11.1 Terumo Corporation
11.1.1 Company Overview
11.2 Smiths Medical
11.2.1 Company Overview
11.3 Novartis AG
11.3.1 Company Overview
11.4 Hospira, Inc.
11.4.1 Company Overview
11.5 GlaxoSmithKline plc
11.5.1 Company Overview
11.6 Fresenius Kabi AG
11.6.1 Company Overview
11.7 Cardinal Health, Inc.
11.7.1 Company Overview
11.8 Boehringer Ingelheim GmbH
11.8.1 Company Overview
11.9 Consort Medical plc
11.9.1 Company Overview
11.9.2 Bespak plc Pipeline Products
11.9.2.1 Bespak plc Pipeline Products By Equipment Type
11.9.2.2 Bespak plc Pipeline Products By Development Stage
11.9.2.3 Bespak plc Pipeline Products By Therapy Area
11.10 Baxter International Inc.
11.10.1 Company Overview
11.11 B. Braun Melsungen AG
11.11.1 Company Overview
11.12 AstraZeneca PLC
11.12.1 Company Overview
11.13 H&O Equipments nv
11.13.1 Company Overview
12 Appendix
12.1 Global Markets Direct Research Methodology
12.2 Secondary Research
12.3 Primary Research
12.4 Models
12.5 Forecasts
12.6 Expert Panel Validation
12.7 Currency Conversion
12.8 Contact Us
12.9 Disclaimer

Executive Summary

1.1 List of Tables
Table 1: Healthcare Expenditure in Belgium, 2000 - 2007 12
Table 2: Hospitals and Hospital Beds in Belgium, 2005 14
Table 3: Number of Doctors by Specialty in Belgium, 2003-2007 15
Table 4: Number of Hospital Wards by Specialty in Belgium, 2003-2007 16
Table 5: Medical Equipment Notification Fee in Belgium, 2007 32
Table 6: Drug Delivery Devices, Belgium, Overall Revenue ($ mn), 2000-2015 35
Table 7: Drug Delivery Devices, Belgium, Cross-Category Analysis, 2000-2015 36
Table 8: Drug Delivery Devices, Belgium, Overall Revenue ($ mn), Historic, 2000-2008 37
Table 9: Drug Delivery Devices, Belgium, Overall Revenue ($ mn), Forecast, 2008-2015 38
Table 10: Drug Delivery Devices, Belgium, Category Volume (Units), 2000-2015 39
Table 11: Drug Delivery Devices, Belgium, Category Volume (Units), Historic, 2000-2008 40
Table 12: Drug Delivery Devices, Belgium, Category Volume (Units), Forecast, 2008-2015 41
Table 13: Drug Delivery Devices, Belgium, Company Share by Revenue ($ mn), 2007-2008 42
Table 14: Infusion Systems, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008 43
Table 15: Infusion Systems, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015 44
Table 16: Infusion Systems, Belgium, Volume (Units) by Segment, Historic, 2000-2008 45
Table 17: Infusion Systems, Belgium, Volume (Units) by Segment, Forecast, 2008-2015 45
Table 18: Infusion Systems, Belgium, Average Price ($), Historic, 2000-2008 46
Table 19: Infusion Systems, Belgium, Average Price ($), Forecast, 2008-2015 46
Table 20: Infusion Systems, Belgium, Distribution Share by Revenue ($mn), 2007-2008 47
Table 21: Infusion Systems, Belgium, Company Share by Revenue ($ mn), 2007-2008 48
Table 22: Inhalation Systems, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008 49
Table 23: Inhalation Systems, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015 50
Table 24: Inhalation Systems, Belgium, Volume (Units) by Segment, Historic, 2000-2008 51
Table 25: Inhalation Systems, Belgium, Volume (Units) by Segment, Forecast, 2008-2015 52
Table 26: Inhalation Systems, Belgium, Average Price ($), Historic, 2000-2008 53
Table 27: Inhalation Systems, Belgium, Average Price ($), Forecast, 2008-2015 53
Table 28: Inhalation Systems, Belgium, Distribution Share by Revenue ($mn), 2007-2008 54
Table 29: Inhalation Systems, Belgium, Company Share by Revenue ($ mn), 2007-2008 55
Table 30: Bespak plc Pipeline Products by Equipment Type 61
Table 31: Bespak plc Pipeline Products By Development Stage 61
Table 32: Bespak plc Pipeline Products By Therapy Area 61
Table 33: USD to Local Currency, Average Exchange Rate 2008 67

Terumo Corporation
Smiths Medical
Novartis AG
Hospira, Inc.
GlaxoSmithKline plc
Fresenius Kabi AG
Cardinal Health, Inc.
Boehringer Ingelheim GmbH
Consort Medical plc
Baxter International Inc.
B. Braun Melsungen AG
AstraZeneca PLC
H&O Equipments nv

Customers who bought this item also bought

• Drug Delivery Devices Market Outlook in Belgium to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
• Belgium Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others
• Belgium Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices
• Belgium Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2015
• Belgium Anesthesia and Respiratory Devices Investment Opportunities, Analysis and Forecasts to 2015
• Belgium In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015
• Neurology Devices Market Outlook in Belgium to 2017 - Neurostimulation Devices, Interventional Neurology and Others
• Belgium In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
• Belgium In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
• Nephrology and Urology Devices Market Outlook in Belgium to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others